Testing and validation are a central component of ensuring the security and continuity of computerized systems. For this reason, automation of testing efforts is an important aspect of an overall automation strategy. This Insight outlines the benefits of test automation and discusses how Selenium can be used to automate processes, like regression tests in Veeva, which have traditionally been done manually.

DevOps has become a bit of a buzzword, its use in practice is often too vague. To demystify the topic, this Insight examines DevOps from a technical perspective. By viewing the concept through the lens of Cloud Computing and Infrastructure as Code (IaC), a fuzzy DevOps concept becomes much more clear.

Ensuring compliance with the European Pharmacopeia (Ph. Eur.) is a cornerstone of European GMP compliance. This Insight highlights the importance of monitor coming changes in the pharmacopeias, and highlights the latest revised general monograph 2.2.46 Chromatographic Separation Techniques.

Pharma IT Consultant Sara Hamilton discusses the important highlights of two reports published in late 2021 which are relevant and informative for improving compliance in pharmacovigilance.

Stig Ragborg highlights why you may want to take a step back to take the right leap forward in your Digitalization for Labs of the Future (LoTF) process. Keep reading to learn more about what you should consider during this process and why you shouldn’t overlook the basics.

Pharma IT Partner, Jakob Juul Rasmussen, highlights the client case of Ascelia Pharma which recently went live on the Pharma IT Cloud EDMS+QMS platform – a secure, and fully GxP-compliant EDMS+QMS solution.

Senior Consultant, Martin Blædel, highlights the latest changes in the guidance on quality of water for pharmaceutical use, as well as their implications for pharmaceutical manufacturing.

The regulatory environment surrounding the pharmaceutical industry is constantly evolving. In this insight, Pharma IT’s Director of Chemistry, Manufacturing, and Control (CMC), Torben Elhauge, highlights two significant Pharmaeuropa developments you should be aware of.